Clinical TrialsSearch results
Number of results: 322
Other
- multicenter phase II study of chemoradiotherapy with docetaxel for elderly patients with stage II, II esophageal cancer
- Esophageal cancer
- National Cancer Center Hospital
- 2009-04-04
Recruiting
- Search for predictors of immune checkpoint inhibitors in patients with malignant pleural mesothelioma
- malignant pleural mesothelioma
- Nakamura Yoichi
- 2021-04-14
Recruiting
- Search for predictors of immune checkpoint inhibitors in MSI-High cancer patients.
- MSI-High cancer
- Nakamura Yoichi
- 2021-04-14
Completed
- Phase I/II Study of Gene Therapy for Parkinson's disease
- Parkinson's disease
- Nakajima Takeshi
- 2022-03-26
Recruiting
- Long-term observational study of Gene Therapy for Parkinson's disease
- Parkinson's disease
- Nakajima Takeshi
- 2022-10-07
Other
- Randamised phase III trial of adjuvant chemotherapy with gemcitabine vs. observation in patients with resectable bile duct cancer
- Bile duct cancer
- Nagoya Surgery Support Organization
- 2007-09-10
Recruiting
- A study on the safety of a low-protein diet for patients with nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
- NAFLD/NASH
- Nagayama Manabu
- 2021-10-27
Other
- Phase III Randomized Adjuvant Study of Exemestane Versus Anastrozole Versus Tamoxifen in Hormone-Responsive Postmenopausal Breast Cancer Patients
- hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 04 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients
- Hormone-responsive postmenopausal primary breast cancer
- N-SAS BC 03 executive committee
- 2005-08-12
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12